(Q34774374)

4 August 2017

1 reference

title

Transition to androgen-independence in prostate cancer (English)

1 reference

4 August 2017

1 reference

Domingo Navarro

1

1 reference

4 August 2017

Octavio P Luzardo

2

1 reference

4 August 2017

Leandro Fernández

3

1 reference

4 August 2017

Nicolás Chesa

4

1 reference

4 August 2017

Bonifacio N Díaz-Chico

5

1 reference

4 August 2017

1 July 2002

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

4 August 2017

1 reference

4 August 2017

81

1 reference

4 August 2017

191-201

1 reference

4 August 2017

3

1 reference

The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Variable expressivity and mutation databases: The androgen receptor gene mutations database

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Androgen receptor--an update of mechanisms of action in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Observations on EGFR gene amplification and polymorphism in prostatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Detection and analysis of beta-catenin mutations in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Rapid signalling by androgen receptor in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Hormonal carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Genetic Linkage Analysis of Prostate Cancer Families to Xq27–28

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

The Nuclear Receptor Resource Project

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Human androgen receptor expression in prostate cancer following androgen ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Androgen receptor transcript level in benign hypertrophy and carcinoma of the human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Androgen-receptor gene structure and function in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Androgen receptor gene amplification increases tissue PSA protein expression in hormone-refractory prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Amplification of the androgen receptor gene is associated with P53 mutation in hormone-refractory recurrent prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Supervillin associates with androgen receptor and modulates its transcriptional activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Androgen blockade in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Ligand-independent activation of the androgen receptor in prostate cancer by growth factors and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Prostate cancer: molecular biology of early progression to androgen independence.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Isolation of cDNAs that are differentially expressed between androgen-dependent and androgen-independent prostate carcinoma cells using differential display PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Prostate specific antigen decline after antiandrogen withdrawal: the flutamide withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

HER2 protein expression and gene amplification in androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900064-X

7 January 2021

10.1016/S0960-0760(02)00064-X

Identifiers

DOI

1 reference

4 August 2017

1 reference